These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


91 related items for PubMed ID: 1924237

  • 1. [Bacteriostatic activity of blood in patients with pulmonary tuberculosis during polychemotherapy].
    Bialik IV, Klimenko MT, Ginzburg TS.
    Probl Tuberk; 1991; (5):25-9. PubMed ID: 1924237
    [Abstract] [Full Text] [Related]

  • 2. [Bacterial excretion and the bacteriostatic activity of the blood in the chemotherapy of middle-aged and elderly tuberculosis patients].
    Ginzburg TS, Iakimets VP.
    Probl Tuberk; 1983 May; (5):57-61. PubMed ID: 6408638
    [No Abstract] [Full Text] [Related]

  • 3. Whole blood bactericidal activity during treatment of pulmonary tuberculosis.
    Wallis RS, Vinhas SA, Johnson JL, Ribeiro FC, Palaci M, Peres RL, Sá RT, Dietze R, Chiunda A, Eisenach K, Ellner JJ.
    J Infect Dis; 2003 Jan 15; 187(2):270-8. PubMed ID: 12552451
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W, Nagayama N, Miyamoto M, Hara H, Suzuki J, Masuda K, Baba M, Tamura A, Nagai H, Akagawa S, Kawabe Y, Machida K, Kurashima A, Yotsumoto H.
    Kekkaku; 2003 Oct 15; 78(10):611-7. PubMed ID: 14621568
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Monitoring of chemotherapy in patients with pulmonary tuberculosis by the blood bacteriostatic activity-determining test].
    Manicheva OA, Skvortsova LA, Pavlova MV, Sapozhnikova NV, Archakova LI, Vishnevskiĭ BI.
    Probl Tuberk Bolezn Legk; 2008 Oct 15; (5):14-7. PubMed ID: 18711812
    [Abstract] [Full Text] [Related]

  • 9. [Methods of determining the bacteriostatic activity of the blood and the primary drug resistance of mycobacteria in pulmonary tuberculosis].
    Bibik NF.
    Probl Tuberk; 1980 Feb 15; (2):63-6. PubMed ID: 6769111
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Dynamics of the release of bacilli and the closing of caverns in newly identified tuberculosis patients undergoing different chemotherapeutic regimens].
    Muratov VV, Pashkov IuN, Pospelov VV.
    Probl Tuberk; 1981 Dec 15; (12):30-4. PubMed ID: 6801646
    [No Abstract] [Full Text] [Related]

  • 13. A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre.
    Int J Tuberc Lung Dis; 1997 Dec 15; 1(6):509-17. PubMed ID: 9487448
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Pulmonary tuberculosis. 2. Therapy].
    Bölcskei P.
    Fortschr Med; 1983 Jun 16; 101(23):1075-80, 1090. PubMed ID: 6411560
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.